I am organizing a Special Issue in Cancers with Eric Chastre & Larissa Kotelevets on PTEN Regulation. 7 papers published so far and deadline is fixed for 31 Dec 2025. Please reach out if you are interested in contributing.
19.07.2025 06:34 — 👍 2 🔁 2 💬 0 📌 0
Delighted to share our new preprint revealing a novel mechanism of ATR inhibitor sensitivity linked to lethal origin firing, thanks Sarah @mcclellandlab.bsky.social and collaborators!
07.03.2025 21:30 — 👍 3 🔁 2 💬 0 📌 0
VIPER-TACs leverage viral E3 ligases for disease-specific targeted protein degradation
www.cell.com/cell-chemica...
06.03.2025 01:12 — 👍 10 🔁 2 💬 0 📌 0
Congrats @lmkdassama.bsky.social and all co-authors for this comprehensive review on biodegraders! A must read.
18.01.2025 11:29 — 👍 0 🔁 1 💬 1 📌 0
Frontiers | Unravelling the druggability and immunological roles of the SOCS-family proteins
Happy to share our latest review on SOCS proteins and their role and therapeutic potential as targets in immunology. To date, drug discovery targeting SOCS proteins have been elusive, due to the difficulty to drug their polar SH2 domain.. 1/3
www.frontiersin.org/journals/imm...
08.12.2024 13:01 — 👍 12 🔁 1 💬 1 📌 0
It was a great pleasure to present @CellSymposia #CSchembio2024 our work on intracellular biodegraders in beautiful San Francisco!! Thanks to the organisers for this opportunity! @mariesorbara.bsky.social
04.12.2024 06:04 — 👍 2 🔁 1 💬 3 📌 0
PhD student
Interested in cell dormancy and therapeutic resistance in Acute Myeloid Leukemia
Dr C. Joffre-Dr M. Ghisi's lab / ADAPTAML team / CRCT
A platform for life sciences. Publications, research protocols, news, events, jobs and more. Sign up at https://www.lifescience.net.
ICMUB (institut de chimie moléculaire de l'Université de Bourgogne)
Université Bourgogne Europe / CNRS / Dijon, France
https://icmub.ube.fr/
A scientific journal publishing cutting-edge methods, tools, analyses, resources, reviews, news and commentary, supporting life sciences research. Posts by the editors.
A scientific journal publishing cutting-edge advances at the intersection of the life and physical sciences. Posts by the editors.
Scientist | Collaborative Leadership Consultant for STEM Leaders and Organizations at the BridgUs Lab
CNRS Researcher - Group Leader @ Institut Cochin - Cell Signalling - Functional Genomics - Cancer Biology - PTEN & p53 Tumour Suppressors
Executive Editor/Team Leader Open Access Science Journals Sage Publishing
Opinions = mine
http://linkedin.com/in/jlovick-editor
#oncology #cancerresearch #medicine #biology #cardiology #neurology #microbiology #publichealth #healthcare #technology
Postdoc in chemical biology at the Technical University of Denmark
RNA, Glycans, Space, Renewable Energy, and all technologies making lives more interesting.
PI at Boston Children’s Hospital SCP
Assistant Professor at Harvard SCRB
https://www.bodegacats.nyc
The ‘Toulouse Institute for Infectious and Inflammatory diseases’ (Infinity) was established January 1st 2021. It is a leading research that is structured along three main themes: Immunology, Inflammatory and Infectious diseases.
The MRC Laboratory of Molecular Biology aims to understand biological processes at the molecular level to help tackle human health problems and disease.
An open-access @natureportfolio.bsky.social journal publishing high quality primary research, reviews and commentary in all areas of the biological sciences since 2018.
https://www.nature.com/commsbio/
Chief Editor @natcomms.nature.com, Cell & Developmental Biology
Previously Comms Bio @commsbio.nature.com, FEBS J, @febsj.bsky.social, JCS @jcellsci.bsky.social
he/him/his
Cambridge-London
Professor @ Scripps Research | Department of Chemistry | chemical biology & chemical proteomics
The CRCL is affiliated with the University Lyon1, Inserm, CNRS and the Leon Bérard Center. It's activity is entirely dedicated to oncology research.
www.crcl.fr
French national network for basic and translational research in pediatric oncology - Understand to treat #Medsky #Oncosky
Postdoctoral Scientist at Barts Cancer Institute
